Bieker et al., 1979 - Google Patents
Investigations in mice on the potentiation of resistance to infections by a new immunostimulant compoundBieker et al., 1979
- Document ID
- 6312810547936026617
- Author
- Bieker U
- Ziegler A
- Hebold G
- Publication year
- Publication venue
- Journal of Infectious Diseases
External Links
Snippet
Abstract BM 12.531, 2-[2-cyanaziridinyl-(1)]-2-[2-carbamoylaziridinyl-(1)]-propane, a new immunostimulant compound, increased the resistance of mice to infection with Candida albicans. Because BM 12.531 had no fungistatic activity in vitro, it is proposed that the …
- 201000009910 diseases by infectious agent 0 title abstract description 36
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4304077B2 (en) | Compositions and methods for the treatment of microbial infections | |
| US3794644A (en) | Pyrrolo-benzodiazepinone compounds | |
| JPH0413628A (en) | Medicine composition for prevention and treatment of clostridium defficile diarrhea and pseudomembranous colitis | |
| US5759554A (en) | Immunostimulatory bacterial cell wall traction | |
| Bieker et al. | Investigations in mice on the potentiation of resistance to infections by a new immunostimulant compound | |
| Specter et al. | Dissociation between the adjuvant vs mitogenic activity of a synthetic muramyl dipeptide for murine splenocytes | |
| Gross | Effects of ascorbic acid on stress and disease in chickens | |
| US20060088514A1 (en) | Formulation comprising a bacterial strain | |
| US20050100531A1 (en) | Probiotic therapies | |
| Schaffner et al. | Lysostaphin: an enzymatic approach to staphylococcal disease. II. In vivo studies | |
| Polk | The enhancement of host defenses against infection—Search for the Holy Grail? | |
| Fernandez et al. | Efficacy of calcium fosfomycin for the treatment of experimental infections of broiler chickens with Escherichia coli O78: K80 | |
| PT655249E (en) | MOENOMYCIN AS A MEDICATION FOR THE TREATMENT OF GASTRIC ULCERS | |
| US6726913B1 (en) | Treatment of dermal tumors, warts, and viral infections of the respiratory tract in humans using heat-killed P. acnes | |
| JPH01311093A (en) | Substituted n-glycosylamides | |
| CN112294789B (en) | Compound preparation for preventing and treating respiratory tract infection and application thereof | |
| DK163566B (en) | USE OF HYGROMYCINE AND EPIHYGROMYCINE FOR THE PREPARATION OF A MEDICINE FOR THE TREATMENT OF PIG DYSENTRY | |
| Marco et al. | Increased rate of survival in Streptococcus pneumoniae-infected rats treated with the new immunomodulator Pidotimod | |
| RU2297842C2 (en) | Method for animal mycotoxicosis prophylaxis | |
| RU2752140C2 (en) | Means and method for improving quality of life of mammals | |
| US3590126A (en) | Chitin antigens and method | |
| US3148113A (en) | Concurrent oral administration of glucosamine with a tetracycline antibiotic for enhanced antibiotic blood levels | |
| JP2001524523A (en) | Use of bicozamycin for the manufacture of a therapeutic agent for hemorrhagic Escherichia coli infection | |
| Jensen et al. | Alterations in Type and Bactericidal Activity of Mouse Peritoneal Phagocytes after Intraperitoneal Administration of Endotoxin | |
| Seu et al. | Therapeutic efficacy of doxycycline against experimental Pasteurella multocida infection in broiler chickens |